EMVision Medical Devices (ASX:EMV) started an aeromedical feasibility and usability study of its first responder brain scanner device, according to a Thursday filing with the Australian bourse.
The study, designed to determine if the device's aeromedical workflow is suitable for use in an emergency aeromedical stroke response, is expected to be completed in the first quarter of fiscal 2026, the filing said.
The company's shares were down 1% in recent Thursday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.